Status:
RECRUITING
Evaluation of Microbial and Endocrinological Parameters in Dialysis Patients With Sepsis
Lead Sponsor:
Western Galilee Hospital-Nahariya
Conditions:
Sepsis
Hemodialysis
Eligibility:
All Genders
18+ years
Brief Summary
This prospective study aims to evaluate the diagnostic value and reliability of blood cultures obtained from different sources-central venous catheter (CVC), dialysis machine, and peripheral vein-in h...
Detailed Description
Chronic kidney disease (CKD) is a major global public health challenge, affecting millions of individuals worldwide. A significant proportion of these patients progress to end-stage kidney disease (ES...
Eligibility Criteria
Inclusion
- hemodialysis patients over the age of 18 who are hospitalized at the Galilee Medical Center due to sepsis and have provided written informed consent to participate in this study.
- \-
Exclusion
- • Patients with cognitive impairment who are unable to provide informed consent.
- \-
Key Trial Info
Start Date :
August 16 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06963853
Start Date
August 16 2022
End Date
December 1 2027
Last Update
May 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Galilee Medical Center
Nahariya, Israel, Israel, 2210001